SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-049978
Filing Date
2023-04-26
Accepted
2023-04-26 09:01:38
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2312635d3_defa14a.htm DEFA14A 11629
2 GRAPHIC tm2312635d3_defa14aimg001.jpg GRAPHIC 159463
3 GRAPHIC tm2312635d3_defa14aimg002.jpg GRAPHIC 112214
  Complete submission text file 0001104659-23-049978.txt   387013
Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Filer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40869 | Film No.: 23846995
SIC: 2834 Pharmaceutical Preparations